Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11343
Title: The clinical role of radionuclide imaging in cardiac transplantation.
Austin Authors: Lee, Katherine J;Wallis, J W;Miller, T R
Affiliation: Department of Nuclear Medicine, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 1-Jul-1990
Publication information: Journal of Thoracic Imaging; 5(3): 73-7
Abstract: Cardiac transplantation is developing into a routine therapy with widespread availability. Nuclear medicine studies play an important role in evaluating potential transplant recipients and in providing documentation of the severity of ventricular dysfunction and the presence of ischemic but viable myocardium. Nuclear cardiology has increased our knowledge of the physiology of cardiac transplants and is now playing an increasing adjunctive role in management. Radionuclide ventriculography performed early after transplantation can identify patients both with abnormal biventricular function resulting from preservation injury and with isolated right ventricular dysfunction. It also provides important functional data that complements the cardiac biopsy in allograft rejection. New techniques such as 111In antimyosin antibodies and 111In lymphocytes have potential value for the accurate, noninvasive diagnosis of rejection. PET promises to improve the ability to diagnose coronary atherosclerosis of the allograft.
Gov't Doc #: 2194042
URI: https://ahro.austin.org.au/austinjspui/handle/1/11343
Journal: Journal of thoracic imaging
URL: https://pubmed.ncbi.nlm.nih.gov/2194042
Type: Journal Article
Subjects: Coronary Disease.radionuclide imaging
Heart Transplantation.methods.physiology
Humans
Radionuclide Ventriculography
Tomography, Emission-Computed
Appears in Collections:Journal articles

Show full item record

Page view(s)

4
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.